Anne-Marie Beausoliel is a prominent inventor based in Redwood City, CA (US). She has made significant contributions to the field of pharmaceutical research, particularly in the development of neprilysin inhibitors. With a total of 4 patents to her name, her work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Among her latest patents, Anne-Marie has focused on compounds that exhibit neprilysin inhibition activity. These compounds are characterized by specific formulas, where R, R, R, and R are defined in the specification, or as pharmaceutically acceptable salts. The inventions also encompass pharmaceutical compositions that include these compounds, methods for their use, and processes for their preparation. This innovative work aims to enhance the efficacy of treatments involving neprilysin inhibitors.

Career Highlights

Anne-Marie Beausoliel is currently associated with Theravance Biopharma R&D IP, LLC, where she continues to advance her research in the pharmaceutical sector. Her expertise and dedication to innovation have positioned her as a key figure in her field.

Collaborations

Throughout her career, Anne-Marie has collaborated with talented individuals such as Melissa Fleury and Adam D. Hughes. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Anne-Marie Beausoliel's contributions to the field of pharmaceuticals, particularly through her work on neprilysin inhibitors, highlight her innovative spirit and commitment to advancing medical science. Her patents and collaborations reflect her significant role in shaping future therapeutic options.

Profile summary based on public USPTO records.